Scope of the report:
The Diabetic Foot Ulcers (DFU) EpiCast Report provides an overview of the risk factors and global trends of DFU in the seven major markets (7MM) (US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the diagnosed incident cases of DFU and total prevalent cases of DFU (diagnosed and undiagnosed cases), which are segmented by sex and age. The diagnosed incident cases of DFU are further segmented by classification of DFUs (neuropathic, ischemic, and neuroischemic). Additionally, the report includes a forecast of the cases of diabetic foot infection and peripheral artery disease (PAD) among the diagnosed incident population of DFUs in the 7MM.
– The DFU epidemiology report is written and developed by Masters- and PhD-level epidemiologists.
– The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.
Diabetic foot ulcers (DFUs) are a common and disabling condition among people with diabetes. Globally, the prevalence of DFU among people with diabetes varies widely, ranging from 5.1% in the UK to approximately 11.9% in Algeria. The lifetime risk of developing a DFU in an individual with diabetes is approximately 25%. DFUs have become an increasingly significant public health concern in both the developed and the developing world, and are a major cause of hospitalizations and the leading cause of lower-extremity amputations in diabetics. Given the increasing prevalence of diabetes coupled with the aging population, the burden of complications related to diabetes such as DFUs is likely to increase over the next 20 years. Request a sample @ http://www.orbisresearch.com/contacts/request-sample/188461 .
GlobalData epidemiologists forecast that the diagnosed incident cases of DFU among the diagnosed diabetic population in the 7 MM will increase from 1,060,036 cases in 2015 to 1,487,754 cases in 2025, at an Annual Growth Rate (AGR) of 4.03%. In the 7MM, GlobalData epidemiologists forecast that the total prevalent cases of DFUs among the diagnosed diabetic population will increase from 4,975,656 cases in 2015 to 7,063,884 cases in 2025, at an AGR of 4.20%.
GlobalData epidemiologists forecast the diagnosed incident cases and total prevalent cases of DFU in the 7MM from 2015-2025 using studies published in peer-reviewed journals that provided age- and sex-specific diagnosed incidence and total prevalence of DFU in the respective markets. GlobalData epidemiologists further segmented the diagnosed incident cases of DFU by classification of DFUs (neuropathic, ischemic, and neuroischemic). Additionally, the report includes a forecast of the cases of diabetic foot infection and peripheral artery disease (PAD) among the diagnosed incident population of DFUs in the 7MM. GlobalData epidemiologists ensured that the forecast methodology was consistent across all the 7MM to allow for a meaningful comparison of the forecast numbers across these markets.
Reasons to buy
The DFU EpiCast report will allow you to –
– Develop business strategies by understanding the trends shaping and driving the global DFU market.
– Quantify patient populations in the global DFU market to improve product design, pricing, and launch plans.
– Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for DFU therapeutics in each of the markets covered.
– Identify the percentage of DFU diagnosed incident cases and total prevalent cases by various clinical segmentations.
Purchase a copy of the report @ http://www.orbisresearch.com/contact/purchase/188461 .
Table of Contents:
1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 6
1.2 List of Figures 7
2 Epidemiology 8
2.1 Disease Background 8
2.2 Risk Factors and Comorbidities 9
2.3 Global Trends 11
2.3.1 Diagnosed Incidence and Total Prevalence 12
2.4 Forecast Methodology 15
2.4.1 Sources Used Tables 16
2.4.2 Forecast Assumptions and Methods 18
2.4.3 Sources Not Used 30
2.5 Epidemiological Forecast of DFU (2015-2025) 31
2.5.1 Diagnosed Incident Cases of DFU Among the Diagnosed Diabetic Population 31
2.5.2 Total Prevalent Cases of DFU Among the Diagnosed Diabetic Population 40
2.6 Discussion 47
2.6.1 Epidemiological Forecast Insight 47
2.6.2 Limitations of the Analysis 48
2.6.3 Strengths of the Analysis 49
3 Appendix 50
3.1 Bibliography 50
3.2 About the Authors 55
3.2.1 Epidemiologists 55
3.2.2 Reviewers 55
3.2.3 Global Director of Therapy Analysis and Epidemiology 56
3.3 About GlobalData 57
3.4 About EpiCast 57
3.5 Disclaimer 58
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customised reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialisation. This helps our clients to map their needs and we produce the perfect required market research study for our clients.